M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Phase 2

Active, not recruiting

Conditions: Waldenstrom's Macroglobulinemia

Interventions: Drug: Bortezomib
Drug: Rituximab
Drug: Valacyclovir

First Posted Date: 2007-06-27

Last Posted Date: 2024-10-11

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 46

Registration Number: NCT00492050

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Evaluation of Single Session Stereotactic Body Radiotherapy

Phase 1

Active, not recruiting

Conditions: Spinal Neoplasms

Interventions: Procedure: Stereotactic Body Radiotherapy

First Posted Date: 2007-06-27

Last Posted Date: 2024-03-07

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 71

Registration Number: NCT00492817

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

Phase 1

Completed

Conditions: Peritoneal Cancer

Interventions: Drug: Bevacizumab
Drug: Oxaliplatin
Drug: Paclitaxel

First Posted Date: 2007-06-26

Last Posted Date: 2013-01-03

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 3

Registration Number: NCT00491855

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Pemetrexed Plus Gemcitabine in Renal Cell Cancer

Phase 2

Terminated

Conditions: Renal Cell Carcinoma

Interventions: Drug: Pemetrexed
Drug: Gemcitabine

First Posted Date: 2007-06-25

Last Posted Date: 2013-04-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 16

Registration Number: NCT00491075

Locations: 🇺🇸
UT MD . Anderson Cancer Center, Houston, Texas, United States

Zoledronate With Atorvastatin in Renal Cell Carcinoma

Phase 2

Completed

Conditions: Kidney Cancer
Renal Cell Carcinoma

Interventions: Drug: Zoledronate
Drug: Atorvastatin

First Posted Date: 2007-06-25

Last Posted Date: 2013-03-18

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 11

Registration Number: NCT00490698

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Active Surveillance in Prostate Cancer

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Survey

First Posted Date: 2007-06-25

Last Posted Date: 2022-04-04

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1139

Registration Number: NCT00490763

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Completed

Conditions: Breast Cancer

Interventions: Procedure: Magnetic Resonance Imaging (MRI)
Procedure: Magnetic Resonance Spectroscopy (MRS)

First Posted Date: 2007-06-22

Last Posted Date: 2022-10-31

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 20

Registration Number: NCT00490503

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer

Not Applicable

Completed

Conditions: Oropharyngeal Cancer
Head and Neck Cancer

Interventions: Radiation: Intensity Modulated Radiation Therapy
Radiation: Adaptive Radiotherapy

First Posted Date: 2007-06-22

Last Posted Date: 2020-12-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 25

Registration Number: NCT00490282

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Data Collection of Demographics and Perioperative Care of Patients Undergoing Laparoscopic Surgery

Terminated

Conditions: Laparoscopy

Interventions: Other: Laparoscopic Surgery Data Collection

First Posted Date: 2007-06-22

Last Posted Date: 2019-01-15

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 31

Registration Number: NCT00490126

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Children's Resiliency, Adjustment, and Coping

Completed

Conditions: Leukemia

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-06-21

Last Posted Date: 2012-02-20

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 66

Registration Number: NCT00489632

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
University of Minnesota Medical Center-Twin Cities, Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy